Several studies have suggested Aβ deposition may be required for the tau accumulation, unlike Aβ, the stage of tau pathology corresponds well with the phase of cognitive decline, which can serve as a predictor of AD progression (Nelson et al., 2012). The gene discussed is MAPT; the disease is Alzheimer disease.